Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Cingulate Inc. (CING)

5.19 -0.06 (-1.14%)
At close: October 29 at 4:00:01 PM EDT
Chart Range Bar
Loading chart for CING
Chart does not reflect overnight price.
  • Previous Close 5.25
  • Open 5.18
  • Bid 3.48 x 200
  • Ask 4.68 x 100
  • Day's Range 5.09 - 5.24
  • 52 Week Range 3.16 - 11.89
  • Volume 38,814
  • Avg. Volume 122,923
  • Market Cap (intraday) 75.472M
  • Beta (5Y Monthly) -0.88
  • PE Ratio (TTM) --
  • EPS (TTM) -3.51
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 21.20

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

www.cingulate.com

14

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CING
19.59%
S&P 500 (^GSPC)
12.78%

1-Year Return

CING
45.79%
S&P 500 (^GSPC)
12.04%

3-Year Return

CING
94.73%
S&P 500 (^GSPC)
87.51%

5-Year Return

CING
99.57%
S&P 500 (^GSPC)
67.64%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -9.31M
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-8M
-6M
-4M
-2M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

8.00
21.20 Average
5.19 Current
44.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/24/2026
Analyst Roth Capital
Rating Action Reiterates
Rating Buy
Price Action Lowers
Price Target 10 -> 9

Statistics

View More

Valuation Measures

Annual
As of 10/28/2026
  • Market Cap

    76.34M

  • Enterprise Value

    54.23M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    3.11

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -66.94%

  • Return on Equity (ttm)

    -198.74%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -28.81M

  • Diluted EPS (ttm)

    -3.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.4M

  • Total Debt/Equity (mrq)

    26.81%

  • Levered Free Cash Flow (ttm)

    -12.84M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

5.19 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 02/22/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 02/21/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 02/17/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 02/16/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: